TGFA has been reported to accelerate cell proliferation, invasion and EMT in breast cancer, prostate cancer and hepatic cancer (39–41) and modulate lung cancer EMT through regulation by PHD3 (42). The gene discussed is EGLN3; the disease is prostate carcinoma.